A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety, Tolerability and Efficacy of Pirfenidone in Patients with Rheumatoid Arthritis Interstitial Lung Disease

Grant

Date/time Interval

  • March 30, 2018 - April 1, 2018

    • Awarded By

    Total Award Amount

  • 0.00

    • Direct Costs

  • 0.00

    • Sponsor Award Id

    • Contributor

  • Joao De Andrade   Principal Investigator  
  • Maria Acosta Lara   Investigator  
  • Maria Danila MD, MSc, MSPH   Investigator  
  • Steven Duncan   Investigator  
  • Tejaswini Kulkarni   Investigator  
  • Tracy Luckhardt   Investigator